Concourse Financial Group Securities, Inc. Heart Beam, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share
Q3 2024 Oct 10, 2024	BUY	$2.0 - $3.1 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$1.8 - $2.94 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$1.39 - $2.41 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$1.13 - $2.5 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$1.93 - $3.26 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$1.93 - $3.26 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$1.83 - $2.95 $0 - $0
Q1 2023 May 15, 2023	BUY	$2.08 - $4.6 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$2.89 - $5.94 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$1.18 - $4.18 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$1.24 - $1.96 $0 - $0
Q1 2022 May 09, 2022	BUY	$1.59 - $3.67 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$2.93 - $4.69 $0 - $0

Others Institutions Holding BEAT

# of Institutions

Shares Held

2.32M

Call Options Held

Put Options Held

View Full List

About HeartBeam, Inc.

Ticker BEAT
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 8,000,870
Market Cap $19.8M
Description
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a ...

More about BEAT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account